Table 1 Therapeutic effect of ZnO NPs on lung oxidative stress markers in P. equorum infected rats.

Noninfected groups

Control

1.89 ± 0.08

2.63 ± 0.23

231.08 ± 14.77

0.69 ± 0.08

538.12 ± 18.66

ZnO NPs (30 mg/kg)

2.07 ± 0.30

2.39 ± 0.16

216.20 ± 4.67

0.59 ± 0.02

584.25 ± 17.29

ZnO NPs (60 mg/kg)

1.95 ± 0.11

2.57 ± 0.04

229.57 ± 4.00

0.64 ± 0.03

544.43 ± 15.24

Infected groups

Vehicle

5.66 ± 0.12^a

1.53 ± 0.12^a

120.46 ± 6.42^a

0.35 ± 0.01^a

1,295.51 ± 11.66^a

ZnO NPs (30 mg/kg)

3.73 ± 0.15^b

1.84 ± 0.15^b

152.45 ± 16.29^b

0.45 ± 0.03^b

917.99 ± 17.66^b

ZnO NPs (60 mg/kg)

2.96 ± 0.30^b

2.31 ± 0.12^b

217.69 ± 18.22^b

0.55 ± 0.03^b

723.72 ± 14.14^b